{name}
{subtitle}
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~61 mi. (Oldenburg, Germany, +145 more cities)
facility
Pius Hospital Oldenburg ( Site 1202)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~66 mi. (Großhansdorf, Germany, +158 more cities)
facility
LungenClinic Grosshansdorf GmbH ( Site 0901)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~66 mi. (Großhansdorf, Germany, +151 more cities)
facility
GSK Investigational Site
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type